bf/NASDAQ:INM_icon.png

NASDAQ:INM

InMed Pharmaceuticals Inc.

  • Stock

3.09

+3.86%

0.84

USD last updated 13/08 01:59:42

Last Close

2.25

13/08 22:04

Market Cap

2.35M

Beta: 1.06

Volume Today

42.41K

Avg: 631.00K

PE Ratio

−0.16

PFCF: −0.24

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -300-200-1002019-05-152020-12-172022-02-142023-06-292024-10-04

    Revenue (Estimate*)

    200M400M600M800M2019-05-152020-12-172022-02-142023-06-292024-10-04

    *Estimate based on analyst consensus